Select your timezone:

Poster Session
Transplant Infectious Diseases and Covid-19

Room: TBD
Track: Covid-19


Enver Akalin, United States
Decreased mortality from SARS-coV-2 infection in kidney transplant recipients over the course of the pandemic

Dr. Mateusz Ogledzinski, United States
Safety and effectiveness of Covid-19 vaccination in the islet transplant recipients

Dr. Liliana Bisigniano MD, Argentina
Argentine COVID 19 Registry transplantation: A national cohort study

Mr. John Black, United Kingdom
Seroprevalence of SARS-CoV-2 antibodies following vaccination amongst renal transplant recipients: A single centre-experience

Dr. Graciela G Bosch B, Argentina
Adaptative strategies implemented by an OPO in argentina for the protection of transplant patients and the OPO's own staff in the context of the SARS-coV-2 pandemic

Dr. Alfredo Chew-Wong, Mexico
Seroconversion in pacients after SARS-cov-2 ChAdOx1 nCoV-19/AZD1222 vaccination in hemodialysis patients and kidney transplant recipients

Dr. Mohamed Elrefaei, United States
Association Between SARS-CoV-2 Infection and De Novo HLA Donor Specific Antibody Production in Lung Transplant Recipients: Single-center study

Dr. Osama Ashry Gheith, Egypt
Covid-19 positive kidney transplant recipients behave differently compared to non-transplant patients ICU: single center experience

Prof. Terence Kee, Singapore
Spectrum of side effects of mRNA COVID-19 vaccine among Asian kidney transplant recipients and healthcare providers at the Singapore General Hospital

Dr. Daniela Kniepeiss, Austria
SARS-CoV-2 vaccination in liver transplant recipients

Prof. Jae Hyun Kwon, Korea
Decreased immunogenicity after SARS-CoV-2 vaccination in liver and kidney transplant recipients

Prof. Jolanta Malyszko, Poland
Mortality in patients on dialyses and kidney transplant recipients during pandemic

Dr. Adriana Carolina C Martínez Cortti Sr., Paraguay
Covid-19 infection in kidney transplant recipients from the IPS: evolution of kidney function and complications

Dr. Ludmila Morcos, Argentina
Impact of vaccination against Covid 19 in the population of intrathoracic transplant recipients during the pandemic

Dr. Gustavo Piccinelli, Argentina
HLA genetic frequency in Renal Transplantation Patients, dead by covid-19

Martin Rumbo, Argentina
Seroconversion in liver and intestine transplant patients after one, two or three doses of adenoviral vector vaccines against SARS-CoV-2. Single center experience in Argentina

Shaifali Sandal, Canada
Analyzing the impact of the COVID-19 pandemic on communication and education strategies across transplant programs in Canada

Ruben O. Schiavelli, Argentina
Behavior of anti- SARS-CoV-2 antibodies in renal transplant patients vaccinated prior to transplantation

Gisela Serra Rodrigues Costa, Brazil
Omicron COVID-19 in Kidney Transplant Recipients

Dr. Marcelo F Taylor, Argentina
Impact of vaccination against SARS CoV2 in kidney transplant recipients

Dr. Shaimaa Z Abdelmegied, Egypt
Graft and patients’ outcome in kidney and simultaneous liver-kidney transplantation with infection control measures and immune suppression adjustment during COVID-19 era

Dr. Ali B. Mahgoub, Qatar
Antibody response to SARS-CoV-2 mRNA vaccine in kidney transplant recipients

Prof. Kenneth L. Brayman, United States
Immunoglobulin M (IgM) delays disease in K18-hACE2 mice infected with SARS-CoV-2

Prof. Kenneth L. Brayman, United States
Adenosine A2A receptor (A2AR) agonists improve survival in K28-hACE2 mice and Syrian hamsters following SARS CoV-2 infection

Walaa Dabbas, United States
A Case of Cytomegalovirus (CMV) Esophagitis Without CMV Viremia After SARS-CoV-2 Infection In A Kidney Transplant Recipient While on CMV Prophylaxis

Dr. Jeethu Joseph Eapen, India
Clinical profile and outcomes of COVID 19 among renal transplant recipients across three waves of SARS CoV2 infection: A multicenter study from South India

Dr. Mehmet Sezen, Turkey
Assessment of the impact of the COVID -19 pandemic on the number of brain deaths, family donations, and organs used between 2019-2020 in the Bursa regional coordination center with the most donors in Turkey

Mrs. Jessica JL Pinto Ramirez PR, Colombia
COVID-19 infection in kidney transplant patients in a Colombian cohort

Dr. Tugba Yanik Yalcin, Turkey
COVID-19 clinical outcomes, coinfection and secondary infections in solid organ transplant recipients

Prof. Yang-Wook Kim, Korea
Comparison of kidney transplant outcomes before and after Coronavirus Disease 2019 pandemic : a single-institution experience

Miss Lucila Martin Rollan, Argentina
Native kidney infection due to non-tuberculous mycobacteria diagnosed by molecular multiplex test in renal transplant: a case report

Dr. Hari Shankar Meshram, India
Pandemic research in organ transplantation from India

Jaqueline Pefaur Penna, Chile
Effectiveness of SARS-cov 2 vaccination in kidney transplant patients in Chile

Dr. Fern Lyse Q. Peñaranda, Philippines
Outcomes of COVID-19 vaccination among Kidney Transplant Recipients admitted for COVID-19 at the National Kidney and Transplant Institute: A Retrospective Study

Ishan Hirji, United States
Healthcare resource utilization in transplant recipients with cytomegalovirus infection refractory to prior treatment with/without resistance receiving maribavir versus investigator-assigned therapy: Exploratory analysis of the Phase 3 SOLSTICE trial

Dr. Mojtaba Shafiekhani, Iran (Islamic Republic of)
Immunogenicity of the inactivated SARS-CoV-2 vaccine (BBIBP-CorV; Sinopharm) and short term clinical outcomes in vaccinated solid organ transplant recipients: a prospective cohort study

Dr. Akos Somoskovi, United States
Physicians’ opinions regarding low-level Epstein-Barr virus DNA levels from PCR testing

Dr. Matej Vnučák, Slovakia (Slovak Republic)
Acute kidney rejection after anti-sars-cov-2 virus-vectored vaccine – case report

Dr. Samuel Chan, Australia
Critically important outcomes for infection in trials in kidney transplantation: an international survey of patients, caregivers and health professionals

© 2024 TTS 2022